Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of the Contact Activation Inhibitor AB023 in Patients with End-Stage Renal Disease on Chronic Hemodialysis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

Christina U Lorentz, PhD, Norah G Verbout, PhD, Joseph J Shatzel, MD, Michael Wallisch, PhD, Brandon D Markway, PhD, Monica T Hinds, PhD, Owen J T McCarty, PhD, David Gailani, MD, Jeffrey I. Weitz, MDFRCPC, Erik I Tucker, PhD, András Gruber, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-139948

Published: 2020

Journal Articles

The Prevalence and Management of Secondary Erythrocytosis in Transgender Individuals Undergoing Masculinizing Therapy

Michael Oakes, MD, Catherine Kato, Shafagh Yazdani, Thomas G. Deloughery, MD, Christina Milano, MD, Joseph J Shatzel, MD, Vikram Raghunathan, MD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-140887

Published: 2020

Journal Articles

Practice Patterns in Hospitalized Adult Patients with Hemophilia: A Survey Study of US Hemophilia Centers

Lubna Khan, Benjamin K Elstrott, BA, Vikram Raghunathan, MD, Sven Reid Olson, MD, Joseph J Shatzel, MD

Blood (2020) 136 (Supplement 1): 26.

https://doi.org/10.1182/blood-2020-141420

Published: 2020

Journal Articles

Tyrosine Kinase Inhibitors (TKIs) Targeting Syk and BTK Signaling Differentially Affect PI3K Signalosome Organization and Platelet Function

Tony Zheng, Elizabeth R Lofurno, Sarah Elgamal, Alexander R Melrose, Jiaqing Pang, Joseph J Shatzel, MD, Owen J T McCarty, PhD, Joseph Aslan, PhD

Blood (2019) 134 (Supplement_1): 2074.

https://doi.org/10.1182/blood-2019-129066

Published: 2019

Journal Articles

Bleeding and Thrombotic Outcomes in Anticoagulant Free Extracorporeal Membrane Oxygenation (ECMO) in Adults: A Systematic Review

Cat R Murphree, MD, Joseph J Shatzel, MD, Sven R Olson, MD

Blood (2019) 134 (Supplement_1): 2436.

https://doi.org/10.1182/blood-2019-125132

Published: 2019

Journal Articles

Safety and Antithrombotic Efficacy of the Recombinant Protein C Activator AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

Norah G Verbout, PhD, Christina U Lorentz, PhD, Brandon D Markway, PhD, Joseph J Shatzel, MD, Erik I Tucker, PhD, Andras Gruber, MD

Blood (2019) 134 (Supplement_1): 2433.

https://doi.org/10.1182/blood-2019-124999

Published: 2019

Journal Articles

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

Arpine Khudanyan, BS, Sven Reid Olson, MD, Thomas G. Deloughery, MD, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 2449.

https://doi.org/10.1182/blood-2019-129653

Published: 2019

Journal Articles

The Safety of Novel Drugs Targeting Factor XI and XII in Human Clinical Trials:a Systematic Review

Gillian E Mair, Sven Reid Olson, MD, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 4966.

https://doi.org/10.1182/blood-2019-130823

Published: 2019

Journal Articles

Predictive and Prognostic Factors Associated with the Incidence and Mortality of Hematologic Malignancies

Emma P. Deloughery, BS, Joseph J Shatzel, MD

Blood (2019) 134 (Supplement_1): 5893.

https://doi.org/10.1182/blood-2019-122075

Published: 2019

Journal Articles

Analysis of the Safety Profile of Direct Oral Anticoagulants Using the FDA Adverse Event Reporting System

Emma P. Deloughery, BS, Joseph J. Shatzel, MD

Blood (2018) 132 (Supplement 1): 2531.

https://doi.org/10.1182/blood-2018-99-109818

Published: 2018

Journal Articles

The Efficacy and Safety of a Catheter Removal Only Strategy for the Treatment of PICC Line Thrombosis Vs Standard of Care Anticoagulation: A Retrospective Review

Joseph J. Shatzel, MD, Dylan Mart, MD, Jeffrey Y. Bien, MD, Ashray Maniar, MD, Sven R Olson, MD, Timothy Liem, MD, Thomas G. Deloughery, MD MACP, FAWM

Blood (2018) 132 (Supplement 1): 1250.

https://doi.org/10.1182/blood-2018-99-115432

Published: 2018

Journal Articles

Analysis of the Safety Profile of Commonly Used Procoagulants Using the FDA Adverse Event Reporting System

Emma P. Deloughery, BS, Joseph J. Shatzel, MD

Blood (2018) 132 (Supplement 1): 4712.

https://doi.org/10.1182/blood-2018-99-109822

Published: 2018

Journal Articles

Thromboprophylaxis with Fixed Dose, 1mg/Kg/Day, Low Molecular Weight Heparin in Adults Undergoing Induction with Asparaginase for Acute Lymphoblastic Leukemia. Results of a Single Institution Cohort Study

Luai S Al Rabadi, MD, Sven Reid Olson, MD, Joseph J. Shatzel, MD, Thomas G. Deloughery, MD MACP, FAWM, Brandon Hayes-Lattin, MD

Blood (2017) 130 (Supplement 1): 2397.

https://doi.org/10.1182/blood.V130.Suppl_1.2397.2397

Published: 2017

Journal Articles

The Safety of Aspirin Vs. Direct Oral Anticoagulants: A Meta-Analysis of Currently Published Clinical Trials

Jeffrey Y. Bien, MD, Molly M. Daughety, Derrick Law Tao, Thomas G. Deloughery, MD MACP, FAWM, Joseph J. Shatzel, MD

Blood (2017) 130 (Supplement 1): 3720.

https://doi.org/10.1182/blood.V130.Suppl_1.3720.3720

Published: 2017

Journal Articles

Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis Results in Improved Hematologic Response Rates: a Single Institution 11 Year Experience

Carlton D. Scharman, MD, Joseph J. Shatzel, MD, Richard T. Maziarz, MD, Eva Medvedova, MD, Alex Stentz, MPH, Gloria Rhyne, MA, Chafic Karam, MD, Rupali S. Avasare, MD, Stephen B. Heitner, MD, Emma C. Scott, MD

Blood (2017) 130 (Supplement 1): 4552.

https://doi.org/10.1182/blood.V130.Suppl_1.4552.4552

Published: 2017

Journal Articles

The Off-Label Use of Four-Factor Prothrombin Complex Concentrate: A Single Institution Retrospective Study

Carlton D. Scharman, MD, Edward Kim, BS, Joseph J. Shatzel, MD, Thomas G. Deloughery, MD MACP, FAWM

Blood (2017) 130 (Supplement 1): 3362.

https://doi.org/10.1182/blood.V130.Suppl_1.3362.3362

Published: 2017

Journal Articles

Uncovering a Covert Enemy: Systemic AL Amyloidosis Associated With Intravascular Diffuse Large B-Cell Lymphoma

Joseph J. Shatzel, MD, Rebecca Wang, BS, Regina C. Lee, MD, Saurabh Malhotra, MD, Kabir Mody, MD, Deborah L. Ornstein, MD, Christopher H. Lowrey, MD

Blood (2013) 122 (21): 5066.

https://doi.org/10.1182/blood.V122.21.5066.5066

Published: 2013

NARROW

Safety and Efficacy of the Contact Activation Inhibitor AB023 in Patients with End-Stage Renal Disease on Chronic Hemodialysis: A Phase 2, Double-Blind, Randomized, Placebo-Controlled Trial

The Prevalence and Management of Secondary Erythrocytosis in Transgender Individuals Undergoing Masculinizing Therapy

Practice Patterns in Hospitalized Adult Patients with Hemophilia: A Survey Study of US Hemophilia Centers

Tyrosine Kinase Inhibitors (TKIs) Targeting Syk and BTK Signaling Differentially Affect PI3K Signalosome Organization and Platelet Function

Bleeding and Thrombotic Outcomes in Anticoagulant Free Extracorporeal Membrane Oxygenation (ECMO) in Adults: A Systematic Review

Safety and Antithrombotic Efficacy of the Recombinant Protein C Activator AB002 (E-WE Thrombin) in End Stage Renal Disease Patients on Chronic Hemodialysis

Efficacy and Safety of Low Molecular Weight Iron Dextran (LMWID) Vs. Ferumoxytol in Treating Iron Deficiency Anemia

The Safety of Novel Drugs Targeting Factor XI and XII in Human Clinical Trials:a Systematic Review

Predictive and Prognostic Factors Associated with the Incidence and Mortality of Hematologic Malignancies

Analysis of the Safety Profile of Direct Oral Anticoagulants Using the FDA Adverse Event Reporting System

The Efficacy and Safety of a Catheter Removal Only Strategy for the Treatment of PICC Line Thrombosis Vs Standard of Care Anticoagulation: A Retrospective Review

Analysis of the Safety Profile of Commonly Used Procoagulants Using the FDA Adverse Event Reporting System

Thromboprophylaxis with Fixed Dose, 1mg/Kg/Day, Low Molecular Weight Heparin in Adults Undergoing Induction with Asparaginase for Acute Lymphoblastic Leukemia. Results of a Single Institution Cohort Study

The Safety of Aspirin Vs. Direct Oral Anticoagulants: A Meta-Analysis of Currently Published Clinical Trials

Autologous Stem Cell Transplant in the Era of Bortezomib-Based Induction for AL Amyloidosis Results in Improved Hematologic Response Rates: a Single Institution 11 Year Experience

The Off-Label Use of Four-Factor Prothrombin Complex Concentrate: A Single Institution Retrospective Study

Uncovering a Covert Enemy: Systemic AL Amyloidosis Associated With Intravascular Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only